1. Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation
   Zhichao Yin et al, 2021, Virologica Sinica CrossRef
2. A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs
   Zaixue Jiang et al, 2021, Frontiers in Immunology CrossRef
3. Preparation and immunoprotective effects of a virus-like particle candidate vaccine of the dominant epidemic D3 genotype coxsackievirus A6 in China
   Xiaoliang Li et al, 2024, Biosafety and Health CrossRef
4. Pulmonary edema following central nervous system lesions induced by a non- mouse-adapted EV71 strain in neonatal BALB/c mice
   Yuefei Jin et al, 2017, Virology Journal CrossRef
5. Enterovirus 71 infection caused neuronal cell death and cytokine expression in cultured rat neural cells
   Cheng‐Yi Chang et al, 2015, IUBMB Life CrossRef
6. Sophocarpine against enterovirus 71 in vitro
   Zengjun Jin et al, 2017, Experimental and Therapeutic Medicine CrossRef
7. Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine
   Minna M. Hankaniemi et al, 2019, Antiviral Research CrossRef
8. Intranasal immunization with coxsackievirus A16 virus-like particles confers protection against lethal infection in neonatal mice
   Xiangpeng Chen et al, 2019, Archives of Virology CrossRef
9. Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein
   Suhaili Mustafa et al, 2020, Vaccines CrossRef
10. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus
    Suvi Heinimäki et al, 2019, Vaccine CrossRef